Skip to main content

Table 7 Responses to pre-activity questions on drug safety information

From: Clinician uptake of obesity-related drug information: a qualitative assessment using continuing medical education activities

CME activity

Activity 2

Activity 3

Sample size

n=1237

n=611

Responses to: Practitioners are asked to report drug adverse events:

A. To MedWatch

B. Only when the adverse event is not specified on the drug label

C. Within 30 days of occurrence, as required by law.

D. Voluntarily, if observed within 30 days of the first dose

Correct (A)

698 (56%)

237 (39%)

Incorrect (B)

85 (7%)

53 (9%)

Incorrect (C)

203 (10%)

174 (29%)

Incorrect (D)

243 (20%)

146 (24%)

Correct vs. Predicted

−14%

−31%